UK Conference Call Takeaways for Healthcare REITs

Washington Analysis Healthcare Team hosted a conference call with a leading UK-based strategic advisor to understand better the potential investment impacts following the announcement that Prime Minister Keir Starmer will abolish NHS England, with relevant roles and responsibilities returned to the Department of Health and Social Care (DHSC). Alongside this announcement, Integrated care boards (ICBs) are facing significant pressures to reduce running costs by approximately 50 percent by October. 2025. Leading industry groups, including large pharmaceutical companies, have highlighted the lack of NHS spending on branded medicines as a long-term barrier to life sciences private investment in the country.

Laura Hobbs
SVP - Healthcare Policy, Washington Analysis

Dr. Monet Stanford
SVP - Healthcare Policy, Washington Analysis

Tatiana Brown Johnson
SVP - Healthcare Policy, Washington Analysis

Ryan Visnovec
Research Assistant, Washington Analysis

Tom King
Consultant, Outside In